JADE201 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

10 results for “JADE201”

Trials

A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis

36 participants · First posted Apr 16, 2026

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

30 participants · First posted Apr 21, 2026

A Single Dose, Phase 1 Study of JADE101 in Healthy Japanese and Chinese Participants

40 participants · First posted Apr 13, 2026

Drugs

RAD201

News

Jade Biosciences Unveils JADE201, Half-Life Extended Anti-BAFF Receptor Antibody for Autoimmune Diseases

Jade Biosciences Advances Three Monoclonal Antibody Programs for Autoimmune Diseases with Phase 1 Data Expected in 2026

Jade Biosciences to Present Preclinical Data on JADE101 Anti-APRIL Antibody for IgA Nephropathy at European Renal Congress